; Biopharmaceutical Market size, Share, Forecast, 2032

Biopharmaceutical Market

Biopharmaceutical Market Size, Share, and Analysis, By Product Type (Purified Proteins, Recombinant Growth Factors, Recombinant Proteins, Recombinant Hormone, Synthetic Immunomodulatory, Monoclonal Antibodies, Vaccines, Other), By Service (Custom Testing / Customer Proprietary Testing, Laboratory Testing, Compendial, and Multi Compendial Laboratory Testing), By Raw Material Type (Active Pharmaceutical Ingredients (API), Formulation Excipients, Compendial Methods (USP/ EP/ JP) Based Vendor Qualification Program Support), By Application (Autoimmune Disorders, Metabolic Disorders, Oncology, Inflammatory and Infectious Diseases, Hormonal Disorders, Neurological Diseases, Cardiovascular Diseases, and Other) and Regional Forecasts, 2022-2032

Published on: Oct-2023
Report Code: FG HC 01683
No. of Pages: 170-350
Report Format: PDF

Product Overview

Biopharmaceutical Market size was USD 311.2 billion in 2021 and projected to grow from USD 376.2 billion in 2023 to USD 895.2 billion by 2032, exhibiting a CAGR of 10.1% during the forecast period.

Biopharmaceuticals are also referred as biologics or biologic drugs which are medical products obtained from biological sources like living organisms, proteins etc. Biopharmaceuticals are the drugs originated using biotechnology procedures and are important in modern healthcare. Biopharmaceuticals are also designed to target specific molecular characteristics of disease related to patients which is a customized treatment.  

Market Highlights

Biopharmaceutical Market is expected to project a CAGR of 10.1% during the forecast period, 2022-2032

Biopharmaceutical Market is expected to reach USD 895.2 billion, growing at a CAGR of 10.1% during forecast period owing to the increasing prevalence of chronic diseases and rising geriatric population which may boost the demand for growth of biopharmaceutical market. Biopharmaceuticals provide targeted therapies and have less side effects along with enhanced efficiency. The increasing research and development activities along with the usage growing usage of monoclonal antibodies in therapeutics of in vitro diagnostics is bolstering the growth of the Biopharmaceutical market.

Biopharmaceutical Market Segmentation

Monoclonal Antibodies segment is expected to grow with high CAGR during the forecast period

Biopharmaceutical Market is classified based on the Product Type into Purified Proteins, Recombinant Growth Factors, Recombinant Proteins, Recombinant Hormone, Synthetic Immunomodulatory, Monoclonal Antibodies, Vaccines, Other. Monoclonal Antibodies is expected to dominate the market in the forecast period owing to the increasing utilization of monoclonal antibodies in therapeutics which are used to treat chronic diseases and is less toxic with low side effects.

Cardiovascular Diseases segment is expected to grow with high CAGR during the forecast period

Biopharmaceutical Market is classified based on the Application into Autoimmune Disorders, Metabolic Disorders, Oncology, Inflammatory and Infectious Diseases, Hormonal Disorders, Neurological Diseases, Cardiovascular Diseases, and Other. Oncology segment dominate the market in 2021 due to the high incidence of various cancers. Cardiovascular Diseases segment is expected to dominate the market in the forecast period owing to the increasing heart attacks and strokes in people of all age groups. The investments by key market players in developing drugs related to CVDs may boost growth of segment sin the market.

Market Dynamics

Growth Drivers

Increasing Necessity of Biopharmaceuticals are Expected to Boost the Growth of the Market

The incidence of various diseases like cardiovascular diseases, diabetes is increasing, and the biopharmaceuticals provide innovative treatment options to target specific issue of diseases and is expected to boost the growth of the market by giving enhanced therapeutic outcomes. The increasing R&D activities related to the medical devices and instruments is also anticipated to drive the demand for the growth of the market. The advancements in technology related to the development of various drug products related to new ailments may also strengthen market growth.

Rising Investment in Healthcare is Expected to Boost the Growth of the Market

Biopharmaceutical industries are aiming in developing the healthcare facilities by improving treatment options which is expected to fortify the growth of the market. The partnerships and collaborations between the market players to upgrade technologies may create growth opportunities. Biopharmaceutical industries are developing targeted therapies and even customising treatment options for particular genetic and molecular disorders of patients.

Restraint

Safety Issues May Restrain the Growth of the Market

Few medications used for treating certain conditions or diseases may have side effects which are expected to restrain the growth of the Biopharmaceutical market due to the safety concerns.

Recent Developments

  • In March 2023, F. Hoffmann-La Roche Ltd declared its collaboration with Eli Lilly to aid in the development of Roche’s Elecsys Amyloid Plasma Panel which is an innovative blood test to aid in early diagnosis of Alzheimer’s disease.
  • In February 2021, The Rockefeller University along with Bristol Myers Squibb revealed agreement of Bristol Myers Squibb on achieving exclusive licence to manufacture, develop, and market Rockefeller's novel monoclonal antibody ("mAb") duo treatment.

Biopharmaceutical Market

Key Players Covered:

  • Amgen Inc.
  • AstraZeneca
  • Johnson & Johnson Private Limited
  • Lilly
  • Pfizer Inc.
  • Sanofi
  • Abbott
  • Novartis AG
  • F. Hoffmann-La Roche Ltd.
  • Novo Nordisk A/S
  • bioMérieux
  • Merck & Co., Inc.
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline Plc
  • Bayer AG
  • Biogen
  • Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)

Regional Analysis

Biopharmaceutical Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. The North America region dominated the biopharmaceuticals market in 2021 due to the presence of well rooted healthcare facilities, accessibility to modern treatment options, and improved patient care in countries of this region.  Asia-Pacific region is expected to dominate the market in the forecast period owing to the growing awareness by government through certain initiatives and increasing advancements in technology which is expected to boost the growth of the market in the forecast period. 

Impact of Covid-19 on Biopharmaceutical Market

The COVID-19 outbreak had resulted in the economic downfall. Several countries had imposed lockdowns and travel bans to control the coronavirus spread. Biopharmaceutical companies had worked enormously for developing vaccines. The supply of raw materials had been delayed due to the pandemic. The production of biologics was increased Several clinical trials were delayed. The attention towards less severe medical conditions were delayed. Covid-19 had a slight negative impact on the growth of Biopharmaceutical Market.

Biopharmaceutical Market is further segmented by region into:

  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
  • Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
  • Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA.

Biopharmaceutical Market Scope and Segments:

ATTRIBUTE

  DETAILS

Study Period

2018-2032

Base Year

2022

Forecast Period

2022-2032

Historical Period

2019-2021

Growth Rate

CAGR of 10.1% from 2022-2032

Unit

Value (USD Billion)

Segmentation

Main Segments List

Product Type

  • Purified Proteins
  • Recombinant Growth Factors
  • Recombinant Proteins
  • Recombinant Hormone
  • Synthetic Immunomodulatory
  • Monoclonal Antibodies
  • Vaccines
  • Other

Service

  • Custom Testing / Customer Proprietary Testing
  • Laboratory Testing
  • Compendial, and Multi Compendial Laboratory Testing

Raw Material Type

  • Active Pharmaceutical Ingredients (API)
  • Formulation Excipients
  • Compendial Methods (USP/ EP/ JP) Based Vendor Qualification Program Support

Application

  • Autoimmune Disorders
  • Metabolic Disorders
  • Oncology
  • Inflammatory and Infectious Diseases
  • Hormonal Disorders
  • Neurological Diseases
  • Cardiovascular Diseases
  • Other

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Frequently Asked Questions (FAQ):

Biopharmaceutical Market size was estimated at USD 311.2 billion in 2021 and is expected to reach USD 895.2 billion in 2032.

Biopharmaceuticals are also referred as biologics or biologic drugs which are medical products obtained from biological sources like living organisms, proteins etc. Biopharmaceuticals are the drugs originated using biotechnology procedures and are important in modern healthcare.

Monoclonal Antibodies and Cardiovascular Diseases segment accounted for the largest Biopharmaceutical market share.

Key players: Amgen Inc., AstraZeneca, Johnson & Johnson Private Limited, Lilly, Pfizer Inc., Sanofi, Abbott, Novartis AG, F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, bioMérieux, Merck & Co., Inc., Bristol-Myers Squibb Company, GlaxoSmithKline Plc, Bayer AG, Biogen and Other Prominent Players are the key players in the Biopharmaceutical Market.

Increasing Necessity of Biopharmaceuticals and Rising Investment in Healthcare are the factors driving the Biopharmaceutical market.

Select License Type

$3199

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at info@fatposglobal.com with your request

Call us

Research Assistance

US : +1 (716) 218-3733
UK : +44 (208) 1235555



Select License Type

$3199

Report accessible by 1 user only

Sample Request

Client Testimonials

FATPOS CLIENT Appriciation DURING THE PROJECT

Clients